M.Pharm in Pharmaceutical Sciences with First class. NET, GATE, GPAT qualified candidates with research experience and publications in peer- reviewed journals will be preferred.
Master Degree in Chemistry, Organic Chemistry, Medicinal Chemistry from a recognized University or equivalent. Hands-on experience in multistep small to large-scale organic synthesis.
Masters Degree in Chemical Sciences With 2 years research experience in organic synthesis OR Masters Degree in Pharmaceutical Sciences With 2 years research experience in organic synthesis
The candidate must have a M.S, M.Pharm, degree in Medicinal chemistry, Natural Products, Pharmaceutical Analysis from a PCI, AICTE, UGC, NAAC recognized, accredited University, Central Autonomous Institutes with 60% marks or above.
To delineate the survival strategy of mycobacteria through antigenic determinants by inhibiting autophagy via miRNA and its significance in host directed therapy
Master Degree in Pharmaceutical Sciences First-class with GPAT qualification Preferably in Pharmaceutics from a recognized University. developing nanoformulations, mammalian cell cultures, and in vivo experiments. Synthesis of Polymers, peptides Characterization of physicochemical Parameter, Determination of anticancer therapeutic effect in the in vitro assay systems, Validation of the in vitro results in the in vivo animal models of tumor-bearing mice model and infectious disease models
M.Sc, BTech in Bio, Chemo, Pharmaco-informatics from a recognised university or Research experience in computational drug discovery. Knowledge of AI/ML would be an added advantage.
BTech, MTech in Biotechnology, Biomedical Engineering, Mechanical Engineering, Chemical Engineering, Polymer Engineering, Materials Engineering or relevant discipline; M.Pharm, MS in Pharmacy, or MSc in Biotechnology, Biochemistry, Zoology, Microbiology, Chemistry